Literature DB >> 2642380

The large vestibular aqueduct syndrome in children. A review of 12 cases and the description of a new clinical entity.

M J Levenson1, S C Parisier, M Jacobs, D R Edelstein.   

Abstract

The large vestibular aqueduct as an isolated anomaly of the temporal bone has been previously identified radiologically, and its association with sensory neural hearing loss has been recognized. It has not, however, been defined as a distinct clinical entity in children. We studied 12 children, ages 3 to 9 years, with downward-fluctuating progressive high-frequency neurosensory hearing losses whose symptoms were thought to be related to the isolated enlargement of the vestibular aqueduct identified by high-resolution computed tomographic scanning. Previously it had been assumed that a large vestibular aqueduct is a temporal bone dysplasia that is a variant of the Mondini type of deformity and that the associated hearing loss is congenital in nature. Our clinical observations, however, indicate that the hearing loss in children with an isolated enlargement of the vestibular aqueduct is acquired during childhood. The natural history of this progressive deafness is reviewed, and a pathophysiologic hypothesis is presented.

Entities:  

Mesh:

Year:  1989        PMID: 2642380     DOI: 10.1001/archotol.1989.01860250056026

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  25 in total

1.  What is a 'Mondini' and what difference does a name make?

Authors:  W W Lo
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

2.  MR imaging of the enlarged endolymphatic duct and sac syndrome by use of a 3D fast asymmetric spin-echo sequence: volume and signal-intensity measurement of the endolymphatic duct and sac and area measurement of the cochlear modiolus.

Authors:  S Naganawa; T Koshikawa; E Iwayama; H Fukatsu; T Ishiguchi; T Ishigaki; M Ikeda; T Nakashima; N Ichinose
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

3.  [Large endolymphatic duct and sac syndrome : part 2: clinical manifestations].

Authors:  S Bartel-Friedrich; M Fuchs; B Amaya; C Rasinski; S Meuret; S Kösling
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

4.  [Large endolymphatic duct and sac syndrome (LEDS) : part I: analysis of imaging findings].

Authors:  S Bartel-Friedrich; B Amaya; C Rasinski; M Fuchs; S Kösling
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

5.  Magnetic resonance imaging of patients with large vestibular aqueducts.

Authors:  T Okumura; H Takahashi; I Honjo; A Takagi; R Azato
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 6.  Hearing loss associated with enlargement of the vestibular aqueduct: mechanistic insights from clinical phenotypes, genotypes, and mouse models.

Authors:  Andrew J Griffith; Philine Wangemann
Journal:  Hear Res       Date:  2011-06-06       Impact factor: 3.208

7.  Inner ear malformations in patients with sensorineural hearing loss: detection with gradient-echo (3DFT-CISS) MRI.

Authors:  J W Casselman; R Kuhweide; W Ampe; G D'Hont; E F Offeciers; W K Faes; G Pattyn
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

8.  Slc26a4 expression prevents fluctuation of hearing in a mouse model of large vestibular aqueduct syndrome.

Authors:  Ayako Nishio; Taku Ito; Hui Cheng; Tracy S Fitzgerald; Philine Wangemann; Andrew J Griffith
Journal:  Neuroscience       Date:  2016-05-04       Impact factor: 3.590

9.  Imaging Evaluation of Pediatric Sensorineural Hearing Loss in Potential Candidates for Cochlear Implantation.

Authors:  Aleena Shafi Jallu; Majid Jehangir; Waqar Ul Hamid; Rafiq Ahmad Pampori
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-01-07

10.  Progressive irreversible hearing loss is caused by stria vascularis degeneration in an Slc26a4-insufficient mouse model of large vestibular aqueduct syndrome.

Authors:  T Ito; A Nishio; P Wangemann; A J Griffith
Journal:  Neuroscience       Date:  2015-09-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.